- Home
- TRDA vs SIBN Comparison
TRDA vs SIBN Comparison
Compare TRDA & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- SIBN
- Stock Information
- Founded
- TRDA 2016
- SIBN 2008
- Country
- TRDA United States
- SIBN United States
- Employees
- TRDA N/A
- SIBN N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- SIBN Medical/Dental Instruments
- Sector
- TRDA Health Care
- SIBN Health Care
- Exchange
- TRDA Nasdaq
- SIBN Nasdaq
- Market Cap
- TRDA 264.5M
- SIBN 733.0M
- IPO Year
- TRDA 2021
- SIBN 2018
- Fundamental
- Price
- TRDA $6.64
- SIBN $17.80
- Analyst Decision
- TRDA Strong Buy
- SIBN Strong Buy
- Analyst Count
- TRDA 3
- SIBN 5
- Target Price
- TRDA $25.67
- SIBN $24.40
- AVG Volume (30 Days)
- TRDA 127.9K
- SIBN 303.0K
- Earning Date
- TRDA 08-12-2025
- SIBN 08-04-2025
- Dividend Yield
- TRDA N/A
- SIBN N/A
- EPS Growth
- TRDA N/A
- SIBN N/A
- EPS
- TRDA 0.61
- SIBN N/A
- Revenue
- TRDA $172,220,000.00
- SIBN $176,601,000.00
- Revenue This Year
- TRDA N/A
- SIBN $19.48
- Revenue Next Year
- TRDA N/A
- SIBN $16.86
- P/E Ratio
- TRDA $10.80
- SIBN N/A
- Revenue Growth
- TRDA 5.74
- SIBN 22.60
- 52 Week Low
- TRDA $6.12
- SIBN $11.70
- 52 Week High
- TRDA $21.79
- SIBN $20.05
- Technical
- Relative Strength Index (RSI)
- TRDA 47.73
- SIBN 52.50
- Support Level
- TRDA $6.18
- SIBN $16.39
- Resistance Level
- TRDA $6.67
- SIBN $17.82
- Average True Range (ATR)
- TRDA 0.34
- SIBN 0.63
- MACD
- TRDA 0.04
- SIBN 0.07
- Stochastic Oscillator
- TRDA 66.67
- SIBN 64.09
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.